Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.

[1]  I. Jeremias,et al.  Important Role of Caspase-8 for Chemosensitivity of ALL Cells , 2011, Clinical Cancer Research.

[2]  J. V. van Dongen,et al.  Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. , 2011, Blood.

[3]  Andrew P. Stubbs,et al.  Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. , 2011, Cancer cell.

[4]  H. Kestler,et al.  Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. , 2011, Cancer cell.

[5]  Andrea Califano,et al.  The TLX1 oncogene drives aneuploidy in T-cell transformation , 2010, Nature Medicine.

[6]  J. Meijerink.  Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia. , 2010, Best practice & research. Clinical haematology.

[7]  A. Hagemeijer,et al.  ABL1 rearrangements in T‐Cell acute lymphoblastic leukemia , 2010, Genes, chromosomes & cancer.

[8]  R. Foà,et al.  Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults , 2010, Haematologica.

[9]  M. Muckenthaler,et al.  High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. , 2009, Blood.

[10]  L. Chin,et al.  High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. , 2009, Blood.

[11]  J. Downing,et al.  Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions , 2009, Leukemia.

[12]  D. Basso,et al.  Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks , 2009, Genes, chromosomes & cancer.

[13]  R. Pieters,et al.  Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia , 2008, British journal of haematology.

[14]  E. Thiel,et al.  Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group , 2008, Leukemia.

[15]  B. Nadel,et al.  The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. , 2007, Blood.

[16]  J. Cayuela,et al.  Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data , 2007, Leukemia.

[17]  Charles Lee,et al.  The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. , 2006, Blood.

[18]  A. Hagemeijer,et al.  Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast , 2006, Leukemia.

[19]  F. Sigaux,et al.  HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.

[20]  M. Caligiuri,et al.  Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia , 2004, The Lancet.

[21]  F. Speleman,et al.  Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. , 2004, Blood.

[22]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[23]  N. Heerema,et al.  Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG) , 2003, Leukemia.

[24]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[25]  J. Zucman‐Rossi,et al.  HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. , 2002, Blood.

[26]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[28]  J. Shuster,et al.  New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. , 2000, Blood.

[29]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[30]  Hsuan-Yu Chen,et al.  Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia. , 2010, Leukemia research.

[31]  A. Hall,et al.  A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. , 2009, Blood.

[32]  W. Kamps,et al.  The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. , 2006, Haematologica.

[33]  J. Zucman‐Rossi,et al.  HOX 11 L 2 expression defines a clinical subtype of pediatric TALL associated with poor prognosis , 2002 .